ArticleTrials2020

Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.

Atsushi Fukunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.